A, E., S, L., WC, W., ME, M., & TI, C. (2026). Nondialyzable versus Dialyzable β -Blockers in Hemodialysis: A Target Trial Emulation Study. Journal of the American Society of Nephrology : JASN. https://doi.org/10.1681/ASN.0000001147
Chicago Style (17th ed.) CitationA, Etemadi, Liu S, Winkelmayer WC, Montez-Rath ME, and Chang TI. "Nondialyzable Versus Dialyzable β -Blockers in Hemodialysis: A Target Trial Emulation Study." Journal of the American Society of Nephrology : JASN 2026. https://doi.org/10.1681/ASN.0000001147.
MLA (9th ed.) CitationA, Etemadi, et al. "Nondialyzable Versus Dialyzable β -Blockers in Hemodialysis: A Target Trial Emulation Study." Journal of the American Society of Nephrology : JASN, 2026, https://doi.org/10.1681/ASN.0000001147.